Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
---|---|---|---|---|
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
US6803046 | BRACCO | Sincalide formulations |
Aug, 2022
(1 year, 7 months ago) |
Kinevac is owned by Bracco.
Kinevac contains Sincalide.
Kinevac has a total of 1 drug patent out of which 1 drug patent has expired.
Expired drug patents of Kinevac are:
Kinevac is available in injectable;injection dosage forms.
The generics of Kinevac are possible to be released after 16 August, 2022.